About Trivascular
Trivascular is a company based in Santa Rosa (United States) founded in 1998 by Joseph Humphrey.. Trivascular has raised $260.95 million across 8 funding rounds from investors including Pinnacle Ventures, Kaiser Permanente Ventures and Redmile Group. The company has 307 employees as of December 31, 2014. Trivascular operates in a competitive market with competitors including Endologix, Endoron Medical, Altura Medical, Aptus Endosystems and Remon Medical, among others.
- Headquarter Santa Rosa, United States
- Employees 307 as on 31 Dec, 2014
- Founders Joseph Humphrey
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$260.95 M (USD)
in 8 rounds
-
Latest Funding Round
$10 M (USD), Post-IPO
Aug 20, 2015
-
Investors
Pinnacle Ventures
& 7 more
-
Employee Count
307
as on Dec 31, 2014
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Trivascular
Trivascular has successfully raised a total of $260.95M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $10 million completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $10.0M
-
First Round
First Round
(31 Mar 2008)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2015 | Amount | Post-IPO - Trivascular | Valuation |
investors |
|
| Dec, 2013 | Amount | Series D - Trivascular | Valuation |
investors |
|
| Nov, 2013 | Amount | Series E - Trivascular | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Trivascular
Trivascular has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Pinnacle Ventures, Kaiser Permanente Ventures and Redmile Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech and Life Sciences focused corporate VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Investments are made in life sciences firms across all stages.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Trivascular
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Trivascular
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Trivascular Comparisons
Competitors of Trivascular
Trivascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endologix, Endoron Medical, Altura Medical, Aptus Endosystems and Remon Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Minimally invasive treatments for aortic disorders are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Endovascular fixation devices for cardiovascular stent grafts are manufactured.
|
|
| domain | founded_year | HQ Location |
Endovascular devices for aortic aneurysms are developed.
|
|
| domain | founded_year | HQ Location |
Endograft anchoring systems for aortic aneurysms are developed.
|
|
| domain | founded_year | HQ Location |
Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Trivascular
When was Trivascular founded?
Trivascular was founded in 1998 and raised its 1st funding round 10 years after it was founded.
Where is Trivascular located?
Trivascular is headquartered in Santa Rosa, United States.
Is Trivascular a funded company?
Trivascular is a funded company, having raised a total of $260.95M across 8 funding rounds to date. The company's 1st funding round was a Series E of $40M, raised on Mar 31, 2008.
How many employees does Trivascular have?
As of Dec 31, 2014, the latest employee count at Trivascular is 307.
What does Trivascular do?
TriVascular was established in 1998 and is based in Santa Rosa, United States. Focus is placed on the medical device sector, where endovascular aortic repair solutions are developed and produced. The Ovation Abdominal Stent Graft System is provided to support treatments for abdominal aortic aneurysms, with FDA approval obtained for its use in clinical procedures. Operations center on innovation in graft profiling technology.
Who are the top competitors of Trivascular?
Trivascular's top competitors include Endologix, Shanghai MicroPort Endovascular MedTech and Jotec.
Who are Trivascular's investors?
Trivascular has 8 investors. Key investors include Pinnacle Ventures, Kaiser Permanente Ventures, Redmile Group, NEA, and Delphi Ventures.